---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-003125"
form_type: "8-K"
ticker: "MD"
cik: "0000893949"
company_name: "Pediatrix Medical Group, Inc."
filed_at: "2023-02-17T23:59:59+00:00"
generated_at: "2026-06-19T08:28:36.398151+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Pediatrix Q4 GAAP EPS $0.29, adjusted $0.47; revenue $514M; 2023 EBITDA guidance $235-245M

## Summary
- Net revenue $513.8M (+3.1% YoY); same-unit patient volume +4.1%; commercial payor mix improved 20 bps.
- GAAP diluted EPS $0.29 vs $0.47; Adjusted EPS $0.47 vs $0.52; CARES Act benefit declined materially.
- Adjusted EBITDA $66.5M vs $81.0M; full year 2022 Adjusted EBITDA $241.0M, GAAP EPS $0.74.
- 2023 preliminary Adjusted EBITDA guidance $235-245M, assuming no additional CARES Act funds.
- Revenue cycle management vendor underperformance partly offset by vendor support; overhead costs reduced.

## SEC filing metadata
- accession: 0000950170-23-003125
- form_type: 8-K
- ticker: MD
- cik: 0000893949
- company_name: Pediatrix Medical Group, Inc.
- filed_at: 2023-02-17T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/893949/000095017023003125/0000950170-23-003125-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/893949/000095017023003125/md-20230217.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-003125
- JSON: https://secwatch.observer/filing/0000950170-23-003125.json
- Plain text: https://secwatch.observer/filing/0000950170-23-003125.txt

## Key facts
- Earnings Releases
  Pediatrix Medical Group, Inc. reported financial results for the twelve months ended December 31, 2022.
  - Period: the twelve months ended December 31, 2022
  - Result: reported results
  source text: On February 17, 2023, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), issued a press release announcing the results of its operations for the three months and twelve months ended December 31, 2022 (the “Fourth Quarter Release”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/893949/000095017023003125/0000950170-23-003125-index.htm
- Earnings Releases
  Pediatrix Medical Group, Inc. reported financial results for the three months ended December 31, 2022.
  - Period: the three months ended December 31, 2022
  - Result: reported results
  source text: On February 17, 2023, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), issued a press release announcing the results of its operations for the three months and twelve months ended December 31, 2022 (the “Fourth Quarter Release”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/893949/000095017023003125/0000950170-23-003125-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.